Abbott Expands Medicare Assistance Program To Include $5 Synthroid Scripts
This article was originally published in The Pink Sheet Daily
Executive Summary
The program will be available to low-income Medicare drug card members who exhaust their $600 annual credit. Abbott’s program already offers Humira free of charge and will be expanded to include chronic condition drugs for $12 per monthly script and Synthroid for $5 per month.
You may also be interested in...
Merck Low-Income Assistance Deals Reached With Most Medicare Rx Card Sponsors
Merck has reached agreements with 34 of 36 card sponsors to offer drugs free of charge once $600 transitional assistance is exhausted.
GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.
Deal Watch: Sanofi, Boehringer Swap Side Businesses
Busy week for AstraZeneca sees buyout of Acerta and acquisition of remaining Daliresp/Daxas worldwide rights from Takeda. Amgen and GSK undo their cancer drug alliances from 2009 and 2010, with all rights reverting to the big biotech.